Private Equity
Andrea Alms Video: Money In Motion 128 - Parkinson's Disease Market
October 2024 - Private Equity
Andrea Alms Video: Money In Motion 128 - Critical Illness Insurance Market
TRANSCRIPT: Hello, my name is Andrea Alms. I am a technology investor and financial manager and this is your money in motion. What is it? Every year about 90,000 people in the U.S. are diagnosed with Parkinson's disease. Parkinson's disease is a neurodegenerative disorder that affects the central nervous system. It is characterized by the gradual loss of dopamine producing cells in the brain, leading to a wide range of motor and non-motor symptoms.
This chronic disease can primarily affects motion, causing tremors, stiffness, and difficulty with balance. The exact cause of Parkinson's disease is still unknown. At transparency, the global Parkinson's Disease Therapeutics market size was 5.1 billion in 2022, forecast to be 9.2 billion by 2031 at a compound average growth rate of 7%. At Acumen Research, the market was 2.5 billion in 2021 and expected to be 6.7 billion by 2030, at a growth rate of 11.5%.
At spherical, the market was 4.9 billion in 2023 and forecast to be 9.1 billion in 2033, at a growth rate of 6.4%. Averaging the averages, the market is 4.2 billion with a growth rate of 8.3%. Thank you. This is your money. Your money in motion.